Abstract
Antenatal corticosteroids, postnatal surfactant treatment, and new strategies for respiratory care have modified the clinical presentation, lung outcome, and survival of extremely low birth weight (ELBW) infants. These changes over the last 10-20 years have resulted in a large population of ELBW survivors that have clinical courses that are quite different from those observed before the general use of surfactant and antenatal corticosteroids. The classic definitions and diagnoses for respiratory problems developed for larger preterm infants may not be accurate for this ELBW population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
